A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg, +17

British Journal of Haematology

Hematological MalignancyImmunohematologyLaboratory HematologyBone Marrow FailureValidated Decision Model +13

Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study Group

Stig Lenhoff, Martin Hjorth, Jan Westin, +15

British Journal of Haematology

Hematological MalignancyIntensive TherapyOncologyTransplantationLongevity +11

Hematopoietic engraftment of dimethyl sulfoxide–depleted autologous peripheral blood progenitor cells

Çiğdem Akalın Akkök, Mette R. Holte, Jon Magnus Tangen, +2

Transfusion

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

Michael Grövdal, Mohsen Karimi, Rasheed Khan, +17

British Journal of Haematology

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Michael Grövdal, Rasheed Khan, Anni Aggerholm, +15

Clinical Cancer Research

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high‐dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma

Ulf‐Henrik Mellqvist, Stig Lenhoff, Hans Erik Johnsen, +5

Cancer

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Astrid Gruber, Magnus Björkholm, L Brinch, +14

Leukemia Research

Hematological MalignancyPsc 833Phase I/ii StudyMedicineMixed-phenotype Acute Leukemia +8

Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial

Dag Torfoss, E. Arne Høiby, Jon Magnus Tangen, +10

Journal of Antimicrobial Chemotherapy

The Agaricus blazei-Based Mushroom Extract, Andosan™, Protects against Intestinal Tumorigenesis in the A/J Min/+ Mouse

Geir Hetland, Dag M. Eide, Jon Magnus Tangen, +3

PLoS ONE

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grövdal, Rasheed Khan, Anni Aggerholm, +15

Blood